摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-{[(1S,2S)-1-(2-chloro-3-fluoro-4-methoxyphenyl)-3,3,3-trifluoro-2-hydroxy-2-(methoxymethyl)propyl]amino}-7-fluoro-1H-quinolin-2-one | 1152781-51-5

中文名称
——
中文别名
——
英文名称
5-{[(1S,2S)-1-(2-chloro-3-fluoro-4-methoxyphenyl)-3,3,3-trifluoro-2-hydroxy-2-(methoxymethyl)propyl]amino}-7-fluoro-1H-quinolin-2-one
英文别名
5-[[(1S,2S)-1-(2-chloro-3-fluoro-4-methoxyphenyl)-3,3,3-trifluoro-2-hydroxy-2-(methoxymethyl)propyl]amino]-7-fluoro-1H-quinolin-2-one
5-{[(1S,2S)-1-(2-chloro-3-fluoro-4-methoxyphenyl)-3,3,3-trifluoro-2-hydroxy-2-(methoxymethyl)propyl]amino}-7-fluoro-1H-quinolin-2-one化学式
CAS
1152781-51-5
化学式
C21H18ClF5N2O4
mdl
——
分子量
492.83
InChiKey
GVVXAENDJXFVQE-VQTJNVASSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.8
  • 重原子数:
    33
  • 可旋转键数:
    7
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.29
  • 拓扑面积:
    79.8
  • 氢给体数:
    3
  • 氢受体数:
    10

反应信息

点击查看最新优质反应信息

文献信息

  • 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, A Process for Their Production and Their Use as Anti-inflammatory Agents
    申请人:Berger Markus
    公开号:US20090137564A1
    公开(公告)日:2009-05-28
    The present invention relates to compounds of formula I, processes for their production and their use as anti-inflammatory agents.
    本发明涉及公式I的化合物,其生产过程以及作为抗炎药物的用途。
  • 5-[(3,3,3-TRIFLUORO-2-HYDROXY-1-ARYLPROPYL)AMINO]-1H-QUINOLIN-2-ONES, A PROCESS FOR THEIR PRODUCTION AND THEIR USE AS ANTI-INFLAMMATORY AGENTS
    申请人:BERGER Markus
    公开号:US20130005766A1
    公开(公告)日:2013-01-03
    The present invention relates to compounds of formula I, processes for their production and their use as anti-inflammatory agents.
    本发明涉及式I的化合物,其制备过程以及其作为抗炎剂的用途。
  • Discovery of the potent non-steroidal glucocorticoid receptor modulator BAY 1003803 as clinical candidate
    作者:Markus Berger、Ekkehard May、Hartmut Rehwinkel、Heike Schäcke、Roland Neuhaus、Antje Rottmann、Thomas M. Zollner、Stefan Jaroch
    DOI:10.1016/j.bmcl.2020.127298
    日期:2020.8
    We report on the discovery of the new clinical candidate BAY 1003803 as glucocorticoid receptor agonist for the topical treatment of psoriasis or severe atopic dermatitis. In the course of optimizing the amino alcohol series as a highly potent new non-steroidal lead structure, considerations were made as to how physicochemical properties and safety concerns relate to structural motifs. BAY 1003803 demonstrates strong anti-inflammatory activity in vitro paired with a pharmacokinetic profile suitable for topical application.
  • 5-[(3,3,3-Trifluoro-2-hydroxy-1-arylpropyl)amino]-1H-quinolin-2-ones, process for their production and their use as anti-inflammatory agents
    申请人:Bayer Intellectual Property GmbH
    公开号:EP2234979B1
    公开(公告)日:2016-05-25
  • SELECTIVE GLUCOCORTICOID RECEPTOR MODIFIERS FOR TREATING IMPAIRED SKIN WOUND HEALING
    申请人:Akribes Biomedical GmbH
    公开号:EP3914249A1
    公开(公告)日:2021-12-01
查看更多